Contraindicated (one)pentobarbital will reduce the level or influence of elbasvir/grazoprevir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. pentobarbital will lessen the extent or impact of ambrisentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unkn